More to See at RSNA 2015: Explore Sessions in Every Subspecialty
Tuesday, Dec. 01, 2015
Here's just a sampling of what RSNA attendees can access in educational courses, scientific sessions and posters and exhibits in every subspecialty. View scientific posters and education exhibits in the Learning Center through Friday. Virtual meeting registrants may also view posters and exhibits by logging on from in or outside McCormick Place.
RC803D (Educational Course)
4-D Flow MRI Quantification?
Friday, Dec. 4, 8:30-10:00 a.m.
MRI flow imaging is based on flow-sensitive, phase contrast sequences. In this session, presenters will introduce the basic MRI physics responsible for imaging flow, extending 1-D flow imaging to 3-D flow imaging used in 4-D flow MRI. Presenters will use examples from valvular and congenital heart disease to illustrate the use of 4-D flow MRI to quantify flow velocities and volumes.
RC515 (Educational Course)
Breast Imaging: Politics and Practice
Wednesday, Dec. 2, 8:10-10:00 a.m.
Presenters will discuss topics related to breast imaging politics and practice in three sessions:
- Current Controversies. Presenters explore evidence supporting screening mammography as it is currently practiced in the U.S., overdiagnosis of breast cancer through screening and the use of MRI and ultrasound in screening high-risk women.
- Economic Challenges. This session covers fundamentals of healthcare payment policy impacting breast imaging, recent developments in payment policy and possible future directions.
- Breast Density. Grassroots political efforts of women with dense breast tissue, imaging options for women with dense tissue and political implications of breast cancer risk due to breast density are covered.
SPSC45 (Educational Course)
Controversy Session: Current USPSTF Lung Cancer Screening: Inclusive or Exclusive
Wednesday, Dec. 2, 4:30-6:00 p.m.
Presenters take on both sides of the U.S. Preventative Services Task Force (USPSTF) lung cancer screening recommendations in two sessions:
USPSTF Lung Cancer Screening, Pro: The session will cover the potential advances of the inclusivity of USPSTF lung cancer screening eligibility criteria, the spectrum of lung cancer risk among patients meeting USPSTF criteria and how personalized risk assessment can facilitate shared decision making for patients meeting the criteria.
USPSTF Lung Cancer Screening, Con: The session will cover the rationale for the USPSTF criteria, the importance of identifying risk among those referred for lung cancer screening, the impact of lung cancer risk on the balance of harms and benefits of lung cancer screening and the clinical and demographic traits that increase the risk for lung cancer.
CH141-ED-X (Education Exhibit)
Essentials of Lung Cancer Screening with Low-dose CT
All Day-Chest (CH) Community, Learning Center
Presenters will review the outcomes of major lung cancer screening trials and evaluate benefits and risks of screening; discuss low-dose CT scanning techniques and strategies for dose reduction; and review current screening guidelines, recommendations and reporting and management standards.
ER153-ED-X (Education Exhibit)
Dose Reduction Techniques for Head CT Following
Traumatic Brain Injuries
All Day-Emergency Room (ER) Community, Learning Center
Presenters will review methods used to decrease the dose of head CTs used to follow traumatic brain injury by decreasing the kV and mAs and using iterative reconstruction to decrease noise and artifact; demonstrate that there is no significant difference in the diagnostic quality of the lower dose head CTs with filtered-back projected or iterative reconstructed images; and review additional traditional methods of reducing dose to radiosensitive organs such as the eyes and thyroid gland.
RC509-03 (Educational Course)
Oral Contrast Media Concentration Selection for Low kVp/keV CT Scanning
Wednesday, Dec. 2, 9-9:10 a.m.
Oral contrast media (OCM) is commonly used for abdominal CT. Clinical implementation of low-kVp/dual energy CT (DECT) imaging demands adjustments in OCM concentration. In this session, presenters research the impact of low X-ray energy (kVp/keV) on OCM using phantom and clinical data and to assess optimal OCM concentrations for low-energy diagnostic CT scans.
SPSC44 (Educational Course)
Controversy Session: Prostate Imaging: Just What MR Technique is Best?
Wednesday, Dec. 2, 4:30-6:00 p.m.
Presenters will review techniques that comprise high-quality multi-parametric MRI (mpMRI) of the prostate. More specifically, they will explore the key protocol questions necessary to set up mpMRI in a radiology practice. After an introduction and overview of mpMRI, sessions will cover:
- 1.5T vs 3T Imaging: Pros and Cons
- Diffusion Weighted Imaging
- Dynamic Contrast-Enhanced Imaging
- Imaging of Recurrence in Prostate Cancer
SPSH40 (Educational Course)
Hot Topic Session: Molecular Imaging and Radionuclide Therapy for Prostate Cancer
Wednesday, Dec. 2, 7:15-8:15 a.m.
Radium-223 is a recently approved therapy for treatment of bone metastases in patients with metastatic prostate carcinoma. In this session, researchers present findings on:
- Ra-223 Therapy for Skeletal Metastases from Prostate Cancer
- Comparison of Ga-68 and F-18 Labeled Small Molecule PSMA Tracers for Prostate Cancer Imaging
- PSMA Ligands for Imaging and
Therapy of Prostate Cancer
RC553 (Educational Course)
Next Generation IT to Improve Quality and Safety
Wednesday, Dec. 2, 8:30-10:00 a.m.
Radiology has been a leader in the adoption and meaningful use of interoperable health information technology (IT) tools supported by federal regulations as part of Health Information Technology and Economic Health Act (HITECH). Presenters will review key, next-generation health IT requirements to improve quality of care and patient safety while reducing waste and use case examples to demonstrate how health IT tools can be used to improve access to imaging, appropriateness of imaging ordering and radiology report value. Enhancing communication of critical test results and enabling appropriate follow-up imaging and care coordination for patients will also be covered.
SSQ17-02 (Scientific Session)
Default Mode Network Structural-functional Connectivity and Beta-Amyloid Pathology in Autosomal Dominant Familial Alzheimer's Disease
Thursday, Dec. 3, 10:40-10:50 a.m.
Early onset familial Alzheimer's disease (FAD) is inherited in an autosomal dominant manner and provides a model for studying how amyloid may affect disease onset and synaptic failure. Using data from Dominantly Inherited Alzheimer's disease Network (DIAN), presenters evaluate relationships between structural connectivity, functional connectivity and amyloid burden. This research received the RSNA Award for Trainee Research Prize—Resident.
SPNM61 (Educational Course)
Theranostics: Contributions of Diagnostic Nuclear Medicine and Targeted Radionuclide Therapy in Clinical Oncology (In Conjunction with SNMMI)Friday, Dec. 4, 8:30-10 a.m.
An important aspect of nuclear medicine and molecular imaging is that the same core compound of the administered radiopharmaceutical can be labeled with gamma emitters (for diagnostic) and beta (or alpha) emitters (for therapy), allowing for targeted treatment of lesions. This is an expression of theranostics—the combination of therapy and diagnostics that is based on the specific tumor biology of each patient's disease. Held in conjunction with the Society of Nuclear Medicine and Molecular Imaging (SNMMI), these sessions will offer several examples of such paired diagnostic studies and treatments using nuclear medicine methods:
- Radioactive Iodine and Thyroid Cancer—Current Use and Controversies
- Bone Scintigraphy and the Use of Radionuclides in the Management of Patients with Metastatic Castrate-Resistant Prostate Cancer
- Updates on the Use of PET/CT (and PET/MRI) and Radioimmunotherapy in Non-Hodgkin's Lymphona
- Peptide Receptor Radionuclide Imaging and Therapy: Where Are We in Europe and What Shall the U.S. Do to Catch Up?
- Selective Internal Radiation Therapy for Hepatic Malignant Lesions
RO262-SD-THB2 (Scientific Poster Discussion)
Sensitivity of Cancer Cells to Radiation
Thursday, Dec. 3, 12:45-1:15 p.m.
Radiation Oncology (RO) Community, Learning Center
Glucosamine, a supplement commonly used for the treatment of osteoarthritis, has been shown to decrease the incidence of adenocarcinoma of the lung and colon, and has also shown to be toxic to cancer cells in vitro at concentrations attainable in humans. Researchers explore the potential of using the nutritional supplement to enhance cancer treatment and investigate whether it is safe for patients to take this supplement while receiving radiation therapy.
Subspecialty content brochures will be available in the Grand Concourse Lobby, Level 3; Lakeside Center, Level 3 and Learning Center.